→Appendix 1: rizatriptan
PDF page 524
▶Common or very common Alertness decreased. asthenia.
diarrhoea. dizziness. drowsiness. dry mouth. dyspepsia.
feeling abnormal. headache. insomnia. musculoskeletal
stiffness. nausea. pain. palpitations. sensation abnormal
. throat complaints. vasodilation. vomiting
▶Uncommon Angioedema. arrhythmias. ataxia.
disorientation. dyspnoea. face oedema. hyperhidrosis.
hypertension. muscle weakness. myalgia. nervousness.
skin reactions. syncope. taste altered. thirst. tongue
swelling. tremor. vertigo. vision blurred
▶Rare or very rare Hypersensitivity. stroke. wheezing
▶Frequency not known Colitis ischaemic. myocardial
infarction. myocardial ischaemia. peripheral vascular
disease. seizure. serotonin syndrome. toxic epidermal
necrolysis
SIDE-EFFECTS, FURTHER INFORMATION Discontinue if
symptoms of heat, heaviness, pressure or tightness
(including throat and chest) occur.
PDF page 524
There is limited experience of using 5HT1-
receptor agonists during pregnancy; manufacturers advise
that they should be avoided unless the potential benefit
outweighs the risk.
PDF page 524
Present in milk in animal studies—
withhold breast-feeding for 24 hours.
PDF page 524
Manufacturer advises caution in
mild to moderate impairment; avoid in severe impairment
(no information available).
Dose adjustments Manufacturer advises dose reduction to
5 mg in mild to moderate impairment.
PDF pages 524, 525
Avoid in severe impairment.
Dose adjustments Reduce dose to 5 mg in mild to moderate
impairment.
PDF page 525